Stocklytics Platform
Asset logo for symbol ICU
LMF Acquisition Opportunities
ICU40
$2.25arrow_drop_up6.13%$0.12
Penny Stock
Asset logo for symbol ICU
ICU40

$2.25

arrow_drop_up6.13%

Performance History

Chart placeholder
Key Stats
Open$2.11
Prev. Close$2.12
EPS-156.59
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$9.24M
PE Ratio-
LOWHIGH
Day Range2.11
2.12
52 Week Range1.83
42.92
Ratios
Revenue-
EBITDA Margin %-
EPS-156.59

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About LMF Acquisition Opportunities (ICU)

SeaStar Medical Holding Corporation (ICU) is a leading company in the healthcare industry, specializing in medical instruments and equipment. With a focus on innovation and quality, SeaStar Medical has established itself as a trusted name in the market. The company's stock price history shows a steady growth over the years, reflecting its strong performance and investor confidence. ICU stock has consistently outperformed the market, providing attractive returns to its shareholders. The company's commitment to research and development has allowed it to introduce cutting-edge medical technologies that meet the evolving needs of healthcare professionals.
SeaStar Medical Holding Corporation (ICU) is renowned for its wide range of medical instruments and equipment. From surgical tools to patient monitoring devices, ICU offers a comprehensive portfolio of products. The company's dedication to quality and safety is evident in its rigorous manufacturing processes and compliance with industry regulations. ICU products have gained a strong reputation for their reliability and effectiveness, positioning the company as a preferred choice among healthcare providers worldwide.
Websitecall_made
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Eric Schlorff
Headquarters
Denver
Employees
9
Exchange
NASDAQ
add LMF Acquisition Opportunities to watchlist

Keep an eye on LMF Acquisition Opportunities

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the 52-week high and low for LMF Acquisition Opportunities (ICU)?

For LMF Acquisition Opportunities (ICU), the 52-week high is $42.92, which is 1.81K% from the current price. The 52-week low is $1.83, the current price is 22.62% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

What is LMF Acquisition Opportunities 's (ICU) price per share?

The current price per share for LMF Acquisition Opportunities (ICU) is $2.25. The stock has seen a price change of $0.13 recently, indicating a 6.13% change. This reflects the stock's recent market performance and investor sentiment.
help

Is LMF Acquisition Opportunities (ICU) a growth stock?

LMF Acquisition Opportunities (ICU) has shown an average price growth of -6.8% over the past three years. It has received a score of 90 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying LMF Acquisition Opportunities as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is LMF Acquisition Opportunities (ICU) stock price performance year to date (YTD)?

As of the latest data, LMF Acquisition Opportunities (ICU) has a year-to-date price change of -80.6%. Over the past month, the stock has experienced a price change of -44.44%. Over the last three months, the change has been -64.29%. Over the past six months, the figure is -78.05%.
help

Is LMF Acquisition Opportunities (ICU) a profitable company?

LMF Acquisition Opportunities (ICU) has a net income of -$26.23M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$14.21M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of LMF Acquisition Opportunities (ICU)?

LMF Acquisition Opportunities (ICU) has a market capitalization of $9.25M. The average daily trading volume is 2.14, indicating the stock's liquidity and investor engagement.

News

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference
SEASTAR MEDICAL
MEDICAL DEVICE
INVESTMENT CONFERENCE
Sep 5, 2024

SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference

DEADLINE ALERT for ICU, MDB, CVS, WBA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
CLASS ACTION LAWSUIT
SHAREHOLDER
SEASTAR MEDICAL HOLDING CORPORATION
MONGODB, INC.
CVS HEALTH CORPORATION
WALGREENS BOOTS ALLIANCE, INC.
Aug 30, 2024

DEADLINE ALERT for ICU, MDB, CVS, WBA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

ICU DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class Action – ICU
SEASTAR MEDICAL HOLDING CORPORATION
SECURITIES CLASS ACTION
INVESTOR RIGHTS
Aug 30, 2024

ICU DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class Action – ICU

SeaStar Medical Holding Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. September 6, 2024 Deadline to file Lead Plaintiff Motion.
SEASTAR MEDICAL HOLDING CORPORATION
CLASS ACTION LAWSUIT
FINANCIAL RESTATEMENT
Aug 30, 2024

SeaStar Medical Holding Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. September 6, 2024 Deadline to file Lead Plaintiff Motion.

The Gross Law Firm Reminds SeaStar Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 6, 2024 – ICU
SEASTAR MEDICAL HOLDING CORPORATION
CLASS ACTION LAWSUIT
HUMANITARIAN DEVICE EXEMPTION
FINANCIAL CONTROLS
Aug 27, 2024

The Gross Law Firm Reminds SeaStar Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 6, 2024 – ICU

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
CVS HEALTH CORPORATION
WALGREENS BOOTS ALLIANCE, INC.
SEASTAR MEDICAL HOLDING CORPORATION
BOLT BIOTHERAPEUTICS, INC.
Aug 27, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm

Take Your Investments to a Whole New Level